| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/1992 | EP0466254A1 2-naphthyl-carbapenems |
| 01/15/1992 | EP0466253A1 2-naphthyl-carbapenems |
| 01/15/1992 | EP0466198A1 A lipoxygenase inhibitor |
| 01/15/1992 | EP0466197A1 A lipoxygenase inhibitor |
| 01/15/1992 | EP0466174A1 Novel physiologically active porcine peptide (CNP-53) |
| 01/15/1992 | EP0466131A2 Pyranobenzoxadiazole derivatives |
| 01/15/1992 | EP0466038A1 Water-dispersible polyene antifungal complexes |
| 01/15/1992 | EP0466037A2 Process for enhancing the resistance of aquatic animals to disease |
| 01/15/1992 | EP0466029A2 Inflammatory bowel disease preventive and curative agents containing zinc l-carnosine salt or complex as active ingredient |
| 01/15/1992 | EP0465970A1 Substituted pyrrolo-pyridines |
| 01/15/1992 | EP0465913A2 Diaminotrifluoromethylpyrimidine derivatives, process for their production and phospholipase A2 inhibitor containing them |
| 01/15/1992 | EP0465841A2 Quick acting pharmaceutical inhalation forms of diuretics |
| 01/15/1992 | EP0465802A1 Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase |
| 01/15/1992 | EP0465663A1 Dermatologic preparation |
| 01/15/1992 | EP0465583A1 Use of a potassic agonist in the treatment of glaucoma |
| 01/15/1992 | EP0465550A1 Pharmaceutical lipid composition for parenteral nutrition. |
| 01/15/1992 | EP0465529A1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 01/15/1992 | EP0465520A1 Sugar composition comprising soluble fibre. |
| 01/15/1992 | EP0465512A1 Regional chemotherapy with 4-hydroperoxycyclophosphamide. |
| 01/15/1992 | EP0465508A1 Dietary supplement for insulin-resistant diabetics |
| 01/15/1992 | EP0344288A4 Method of inhibiting the activity of leukocyte derived cytokines |
| 01/15/1992 | EP0333756B1 1,2-diaminocyclohexane-platinum complexes with antitumor activity |
| 01/15/1992 | EP0237573B1 Novel benzothiazine derivatives |
| 01/15/1992 | EP0232405B1 Soluble phosphorylated glucan |
| 01/15/1992 | CN1057844A Process for preparation of pyrimidine nucleosides |
| 01/15/1992 | CN1057843A Novel 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents |
| 01/15/1992 | CN1057842A Bis(4-(2,6-di-alkyl) phenol) silane derivatives as antiathe-rosclerotic agents |
| 01/15/1992 | CN1057840A Antiviral tetrahydroimioazo (1,4) benzodiazepin-2-(thi) ones |
| 01/15/1992 | CN1057839A Azabenzimidazoles in treatment of asthma, arthritis and related diseases |
| 01/15/1992 | CN1057834A Amide linked pyridyl-benzoic acid derivatives for treating leukotriene-related diseases |
| 01/15/1992 | CN1057780A Formulations |
| 01/14/1992 | WO1992000988A1 Targeted drug delivery via phosphonate derivatives |
| 01/14/1992 | WO1992000978A1 Imidazopyridine paf antagonists |
| 01/14/1992 | WO1992000965A1 Neuromuscular blocking agents |
| 01/14/1992 | US5081284 N-Oxomethyl-Substituted Peptide |
| 01/14/1992 | US5081282 Prostaglandins |
| 01/14/1992 | US5081271 Novel benzoic acid derivatives and process for preparing the same |
| 01/14/1992 | US5081264 Bioxanthracene derivatives |
| 01/14/1992 | US5081253 Imidazo(4,5-c)pyridines as antiosteoporotic agents |
| 01/14/1992 | US5081237 3-alkenyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds |
| 01/14/1992 | US5081234 Antitumor agents |
| 01/14/1992 | US5081158 Compositions and in situ methods for forming films on body tissue |
| 01/14/1992 | US5081157 Compositions and in situ methods for forming films on body tissue |
| 01/14/1992 | US5081156 Sustained-release preparation |
| 01/14/1992 | US5081153 Metaclopramide as antiemetic for cancer chemotherapy |
| 01/14/1992 | US5081152 Azulene derivatives as thromboxane a2 and prostaglandin endoperoxide receptor antagonist |
| 01/14/1992 | US5081151 Method of growing hair |
| 01/14/1992 | US5081149 Antihepatopathic method |
| 01/14/1992 | US5081148 Blocking agents of edrf effect or formation for the treatment of shock |
| 01/14/1992 | US5081137 Antidepressants |
| 01/14/1992 | US5081136 1,2,3-triazole compounds active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them |
| 01/14/1992 | US5081135 Bactericides |
| 01/14/1992 | US5081130 Derivatives of 1-arylsulphonyl-2-pyrrolidinone, their preparation process, intermediates thereof, their use as medicaments and compositions containing them |
| 01/14/1992 | US5081129 Method of treatment of anemia with seratonin antagonists |
| 01/14/1992 | US5081128 2,3-dihydro-1h-isoindole derivatives and their application in therapy |
| 01/14/1992 | US5081126 Quinolyl- and isoquinolyl-methoxyphenyl-dithioacetyl derivatives useful as antiinflammatory agents |
| 01/14/1992 | US5081125 Anthelmintics |
| 01/14/1992 | US5081124 Amino acid and polyamino acid derivatives, inhibitors of thymidylate synthetase |
| 01/14/1992 | US5081123 Quinoxaline compound and their preparation and use |
| 01/14/1992 | US5081122 Antiglaucoma compositions containing 4-arylcarbonyl-1-(4-morpholinyl)-lower-alkyl)-1H-indoles and method of use thereof |
| 01/14/1992 | US5081120 Analgesics |
| 01/14/1992 | US5081119 Use of 5-alkylpyridazine derivatives as drugs active on the cholinergic system |
| 01/14/1992 | US5081118 Benzothiazine dioxide derivatives |
| 01/14/1992 | US5081117 Treatment of memory dysfunctions such as in Alzheimer's disease |
| 01/14/1992 | US5081116 Cephalosporin derivatives |
| 01/14/1992 | US5081115 Method to prevent neonatal jaundice with metalloporphyrin compositions |
| 01/14/1992 | US5081114 Aromatase enzyme inhibitor, cancer therapy |
| 01/14/1992 | US5081113 Novel 3-keto-steroids |
| 01/14/1992 | US5081112 Method for treating hyperlipidemia |
| 01/14/1992 | US5081110 Method of killing sarcoma cells using fludarabine phosphate and ionizing radiation |
| 01/14/1992 | US5081109 Pharmaceutical composition and method for the therapy of peripheral arteriopathies |
| 01/14/1992 | US5081105 Method of treating cancer using structured lipids |
| 01/14/1992 | US5080909 Lithium Salt, Vidarabine, Synergistic |
| 01/14/1992 | US5080908 Vitamin b12 composition |
| 01/14/1992 | US5080906 Method and composition for oral administration of n-acetylcysteine |
| 01/14/1992 | US5080905 Therapy of 10-amino-5,6-dihydro-11h-dibenzo(b,e)azepine-6,11-dione and derivatives as drugs for use in the treatment of urinary incontinence |
| 01/14/1992 | US5080903 Galenical forms of beta-2-mimetics for administration perlingually and sublingually |
| 01/14/1992 | US5080902 Article and a prophylactic composition containing a microbicide |
| 01/14/1992 | US5080899 Method of treating pulmonary inflammation |
| 01/14/1992 | US5080898 Enzymatically active toxin coupled to a cell-specific ligand |
| 01/14/1992 | US5080894 Injection of ethylene oxide-propylene oxide copolymer and oxygen free radical scavenger; antiischemic agents |
| 01/14/1992 | US5080893 Wet coating of polysaccharide |
| 01/14/1992 | US5080885 Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport |
| 01/14/1992 | CA2087194A1 Targeted drug delivery via phosphonate derivatives |
| 01/14/1992 | CA2083056A1 Imidazopyridine paf antagonists |
| 01/14/1992 | CA2046734A1 Substituted pyrrolo-pyridines pharmaceuticals |
| 01/14/1992 | CA2046006A1 Thioxo heterocycles |
| 01/14/1992 | CA2042502A1 Zinc carbocysteinate, compositions thereof and process of preparation of said compositions |
| 01/14/1992 | CA1294284C 3-demethylmevalonic acid derivatives, a process for their preparation, pharmaceutical products based on these compounds, their use and intermediates |
| 01/14/1992 | CA1294282C 2-phenylpyrano¬2,3-b|pyridine compounds and process for their preparation |
| 01/14/1992 | CA1294281C Specific 5-ht--antagonists |
| 01/14/1992 | CA1294280C 2-azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof, processes for the preparation thereof, agents containing same, and the use thereof |
| 01/14/1992 | CA1294279C 2-substituted 5-monoaryl-as-3-triazinones, process for their preparation and application thereof as medicinal agents |
| 01/14/1992 | CA1294278C Naphthalene derivative and processes for preparing same |
| 01/14/1992 | CA1294276C Benzothiazine dioxide derivatives |
| 01/14/1992 | CA1294274C Method of treating muscle tension, muscle spasticity and anxiety with 3-aryloxy-azetidinecarboxamides |
| 01/14/1992 | CA1294273C Sulphonamido 3-benzazepine derivatives as antiarrhythmic agents |
| 01/14/1992 | CA1294218C Method and agents for inhibiting protein aging |
| 01/14/1992 | CA1294217C Pharmaceutical formulation for the treatment of bacterial infections |
| 01/14/1992 | CA1294216C Coccidiocidal agents comprising a polyether antibiotic |